Berkovic, S., Johns, J. & Bladin, P. (1982) Focal seizures and systemic metabolic disorders. Australian and New Zealand Journal of Medicine, 12, 620–623.
Henderson, D., Cagliero, E., Gray, C., et al (2000) Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five year naturalistic study. American Journal of Psychiatry, 157, 975–981.
Moores, C. & Dire, D. (1989) Movement disorders as a manifestation of nonketotic hyperglycaemia. Journal of Emergency Medicine, 7, 359–364.
Safferman, A., Lieberman, J., Kane, J., et al (1991) Update of the clinical efficacy and side effects of clozapine. Schizophrenia Bulletin, 17, 247–261.
Sajatovic, M. & Meltzer, H. (1996) Clozapine-induced myoclonus and generalized seizures. Biological Psychiatry, 39, 367–370.